Trump Nominates Overton to Lead FDA

ArchivedSources Agree
  • August 19, 2026 at 1:49 PM ET
  • Est. Read: 2 Mins
Trump Nominates Overton to Lead FDAAI-generated illustration — does not depict real events
Listen to This SummaryAI-generated audio

Key Takeaways

President Donald Trump has nominated Dr. Heidi Overton to lead the Food and Drug Administration (FDA). She will replace former commissioner Marty Makary, who resigned amid policy disputes.

  • President Trump nominates Dr. Heidi Overton for FDA commissioner
  • Overton replaces Marty Makary, who resigned in May 2024
  • Overton currently serves as deputy director of the White House Domestic Policy Council
  • She holds medical and doctoral degrees from UNM and Johns Hopkins
  • Nomination follows her role in shaping Trump's health policies

Source Claims Check

High Consensus
All 14 publishers report consistent facts across 5 key claims.
ClaimStatusReason
Overton's NominationBroad AgreementTrump nominates Dr. Heidi Overton for FDA commissioner
Makary's ResignationBroad AgreementMakary resigned as FDA commissioner in May 2024
Overton's Current RoleBroad AgreementOverton is deputy director of the White House Domestic Policy Council
Overton's Educational BackgroundBroad AgreementMD from UNM, PhD from Johns Hopkins
Trump's Praise For OvertonBroad AgreementTrump calls Overton a 'rockstar' on Truth Social
Overton's Nomination
Broad Agreement
Trump nominates Dr. Heidi Overton for FDA commissioner
Makary's Resignation
Broad Agreement
Makary resigned as FDA commissioner in May 2024
Overton's Current Role
Broad Agreement
Overton is deputy director of the White House Domestic Policy Council
Overton's Educational Background
Broad Agreement
MD from UNM, PhD from Johns Hopkins
Trump's Praise For Overton
Broad Agreement
Trump calls Overton a 'rockstar' on Truth Social
This analysis is AI-generated and may not perfectly represent each source's reporting. Always read the original articles for full context.

President Donald Trump has nominated Dr. Heidi Overton, the deputy director of the White House Domestic Policy Council, to be the next commissioner of the Food and Drug Administration (FDA). If confirmed by the Senate, she will replace former commissioner Marty Makary, who resigned in May amid policy disputes with White House advisers.

Overton holds a medical degree from the University of New Mexico School of Medicine and earned a doctorate in clinical investigation from Johns Hopkins Bloomberg School of Public Health. She is board-certified in public health and general preventive medicine and previously worked under Makary during his tenure at the hospital. Overton has been influential in shaping significant health policies within the Trump administration, including overhauling childhood vaccine schedules and altering dietary guidelines.

Trump praised Overton on Truth Social, describing her as a 'rockstar' who has tackled some of the hardest issues, bringing solutions that work best for the country. The nomination follows Overton's role in shaping significant health policies within the Trump administration, including overhauling childhood vaccine schedules and altering dietary guidelines.

Overton's appointment is seen as part of Trump's push to implement his 'America First' policies at the FDA, which has lost more than 3,000 staff over the past year. She previously worked at the America First Policy Institute, a conservative think tank. The nomination has sparked mixed reactions from various stakeholders. Republican Sen. Bill Cassidy of Louisiana expressed concerns about Overton's lack of managerial experience and her role in the controversial vaccine executive order.

How this summary was created

This summary synthesizes reporting from 14 independent publishers using AI. All sources are cited and linked below. NewsBalance is a news aggregator and media literacy tool, not a news publisher. AI-generated content may contain errors or inaccuracies — always verify important information with the original sources.

Read our full methodology →

Read the original reporting ↓